Benzphetamine

From WikiMD's WELLNESSPEDIA

(Redirected from Didrex)

Benzphetamine

Benzphetamine is a stimulant that is used as an anorectic or appetite suppressant in the treatment of obesity. It is chemically related to amphetamines, which are a group of psychoactive drugs that stimulate the central nervous system and have effects on physical energy, mood, and appetite. Benzphetamine is marketed under various brand names, such as Didrex among others.

Medical Uses[edit]

Benzphetamine is primarily prescribed for the short-term management of obesity, alongside diet, exercise, and behavior modification. It is intended for use in individuals with a body mass index (BMI) that is significantly higher than what is considered healthy and who have not been able to lose weight with diet and exercise alone.

Pharmacology[edit]

Benzphetamine works by stimulating the release of norepinephrine and dopamine, two neurotransmitters that have a significant impact on hunger and satiety. By increasing the levels of these neurotransmitters, benzphetamine reduces appetite, leading to a decrease in food intake and an increase in energy expenditure. Unlike some other appetite suppressants, benzphetamine does not have a significant effect on serotonin levels.

Side Effects[edit]

The use of benzphetamine can lead to a range of side effects, some of which may be serious. Common side effects include insomnia, dry mouth, nausea, and increased heart rate. More severe side effects may include hypertension, heart palpitations, and psychosis. Due to its chemical similarity to amphetamines, there is also a risk of dependence and abuse.

Contraindications[edit]

Benzphetamine is contraindicated in individuals with a history of cardiovascular disease, hyperthyroidism, glaucoma, and drug abuse. It should also not be used in combination with other central nervous system stimulants or within 14 days of taking a monoamine oxidase inhibitor (MAOI).

Regulation[edit]

In many countries, benzphetamine is classified as a controlled substance due to its potential for abuse and dependence. Its use is regulated, and it is available only with a prescription from a licensed healthcare provider.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.